Delivery Order SPE2DB20D3505-SPE2DB25FU2G1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,075.75 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. This non-set-aside contract was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, and operates under firm fixed price terms. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,591.08 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in a 12-gram inhaler. This non-set-aside, competitively awarded contract carries a firm fixed price structure with an ultimate completion date of December 3, 2025. The product will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,301.76 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate HFA 110 mcg inhalers (12-gram containers). This contract, awarded on November 6, 2025, with an ultimate completion date of November 7, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $4,955.90 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. This non-set-aside, competitively awarded contract carries a firm fixed price structure with an ultimate completion date of June 27, 2025, one day after the award date. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 44 micrograms in a 10.6-gram inhaler, valued at $5,426.82, with an award date of November 24, 2025, and ultimate completion by November 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,260.24 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 mcg inhalers (12 grams) on November 26, 2025, with completion expected by November 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, valued at $1,184.52, with an ultimate completion date of August 4, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a prime pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,379.83 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of October 23, 2025. AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This...
- The Defense Logistics Agency awarded a delivery order valued at $16,946.14 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. This competitive award, announced on August 15, 2025, with an ultimate completion date of August 18, 2025, utilizes firm fixed pricing and carries no set-aside designation. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $1,817.31 delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 44 micrograms in a 10.6-gram inhaler, with an ultimate completion date of September 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine medical supply procurement under AmerisourceBergen's...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FU2G1Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,503.91 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in a 12-gram inhaler. This is a firm fixed price, non-set-aside contract with a completion date of March 20, 2025, just one day after the award date of March 19, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 3/19/25 |